Navigation Links
Multiple Campylobacter Genomes Sequenced

In 1995, the first complete bacterial genome sequence was published. Now, nearly 200 bacterial genomes have been completed, and a new one hits the scientific press most weeks. This burgeoning industry is not just scientific “stamp collecting,?however. Having all these genome sequences may provide useful clues about why some bacteria cause human disease, how to control their spread, and how to treat the infections caused by them. By comparing genome sequences, scientists can learn much more about what makes a bacteria tick than they can learn from a single sequence.

Derrick Fouts and his colleagues have taken this comparative approach with Campylobacter. Infection with a Campylobacter species is one of the most common causes of human bacterial gastroenteritis. In the US, 15 out of every 100,000 people are diagnosed with campylobacteriosis every year, and with many cases going unreported, up to 0.5% of the general population may unknowingly harbor Campylobacter in their gut annually. Diarrhea, cramps, abdominal pain, and fever develop within 2? days of picking up a pathogenic Campylobacter species, and in most people, the illness lasts for 7?0 days. But the infection can sometimes be fatal, and some individuals develop Guillain-Barré syndrome, in which the nerves that join the spinal cord and brain to the rest of the body are damaged, sometimes permanently.

Campylobacteriosis is usually caused by C. jejuni, a spiral-shaped bacterium normally found in cattle, swine, and birds, where it causes no problems. But the illness can also be caused by C. coli (also found in cattle, swine, and birds), C. upsaliensis (found in cats and dogs), and C. lari (present in seabirds in particular). Disease-causing bacteria generally get into people via contaminated food, often undercooked or poorly handled poultry, although contact with contaminated water, livestock, or household pets can also cause disease.

In 2000, C. jejuni was the first food-borne pathogen to b
'"/>

Source:PLoS Biology


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
3. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
4. OHSU researchers discover potential mechanism to repair brain damage linked to Multiple Sclerosis
5. Multiple genes permit closely related fish species to mix and match their color vision
6. Multiple malaria infection inhibits spread of parasite

Post Your Comments:
(Date:11/24/2009)...t keep weakened and flabby arteries from collapsin..., those stents are no longer needed -- once the ar...Previously, doctors had no choice but to leave the... University,s Department of Biomedical Engineering... that carries drugs where they,re needed, then dis...
(Date:11/24/2009)...UGE Antarctica has long held secrets of the earth...ently, there has been very little information on t...s of ice for millions of years. Now, a team of res...ve been funded to the tune of $10 million dollars ... to the bottom of things literally. These scienti...
(Date:11/23/2009)...New research presents strong evidence that the "sy...utdoor traffic-related pollution and indoor endoto...or the other exposure alone. , Environmental h...UC) College of Medicine have shown that children e...icles and indoor endotoxin during early life are s...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Prostate cancer gives a new outlook on life 58853 1Prostate cancer gives a new outlook on life 58853 2University of Washington receives 2425 million to create Northwest Genomics Center 10256 1University of Washington receives 2425 million to create Northwest Genomics Center 10256 2University of Washington receives 2425 million to create Northwest Genomics Center 10256 3University of Washington receives 2425 million to create Northwest Genomics Center 10256 4Focused Radiation Protects Tumor Patients Brain Function 58850 1Focused Radiation Protects Tumor Patients Brain Function 58850 2
... in response to higher global temperatures may be ...count plants, ability to adjust to changing condit...onal Laboratory. , In a Perspectives paper publish...tes ORNL findings suggesting that about 9 percent ... the acclimation of plants included in the model. ...
...bage-eating moth may one day provide a safer, targ...y, researchers say. , , They compared the abilit... transposons, to insert themselves into a cell,s D...e cell resistant to damage from radiation therapy....o 10 times better than the other circular pieces o...
...nia, Los Angeles have defined conditions associate...n almost a third of breast cancer survivors, accor...ncer Research. , The key to their fatigue stems ...hese studies identify a biological basis for persi...ted by inflammation," said Michael Irwin, M.D., di...
Other Biology News:Plants' role in global warming re-examined 2Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3Inflammation markers identify fatigue in breast cancer survivors 2
(Date:11/23/2009)...v. 23, 2009 In a provocative new study, a Univers...oxide emissions the major cause of global warming...collapses or society builds the equivalent of one ...nlikely that there will be any substantial near-te...n carbon dioxide emission rates," says the new pap...
(Date:11/23/2009)...romises ultra-fast communication, computation and ...n. But trying to use quantum states as carriers of...w two physicists have shown, mathematically, how t...nication, while keeping the information intact. Th...ical Review Letters and highlighted with a Viewpo...
(Date:11/23/2009)...E,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBioPharma,...sestablishedNovember27,2009astheex-dividenddatefor...ngfromthesecuritizationtransactioncompletedonNovem...allstockholdersofrecordontherecorddate,December1,2...ividendat$1.67pershareofcommonstockforpurposesofth...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--NeogenCorporation(N....D.,waselectedtoNeogen,sBoardofDirectorsatthecompa...erhasmorethan40yearsofexperienceinthefood,agricult...tprofessorofagriculturaleconomicsatVirginiaTechUni...edStateschiefagriculturenegotiatorwiththerankofamb...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2
...ific (NYSE: BSX ) today announced special items ...uarter. The Company plans to release its first qu...ompany disclosed last month, the Court of Appeals ...s decision that Johnson & Johnson,s (J&J) ...e Boston Scientific,s patent and that the patent i...
...gnostics,Incorporated (NYSE: DGX ) today announc...osed federal government investigation related to c...anufacturing subsidiary closed,voluntarily in 2006... since,its investigation began in 2004. , Ques...civil investigation.,While the company disagrees w...
...announced today that it,has completed the formatio...ment its existing group of Senior Advisers. NexBi... of DAS181 (Fludase(R)), an investigational drug,c...Bio throughout the clinical,development of this no...ced,product development to address the threat of a...
Other Biology Technology:Boston Scientific Announces First Quarter Special Items 2Boston Scientific Announces First Quarter Special Items 3Boston Scientific Announces First Quarter Special Items 4Boston Scientific Announces First Quarter Special Items 5Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 3NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 4
EDTA Solution (pH 8.0) (0.5 M) from BioVision
Rat Anti-Mouse Limitin Monoclonal Antibody, Unconjugated, Clone 183727 from R&D Systems
Normal Human Serum from CHEMICON
Human HGF, Unconjugated from R&D Systems
Biology Products: